Want to see CTKB full AI Analyst Report?
Cytek Biosciences (CTKB) Income Statement
Cytek Biosciences Income Statement
Last quarter (Q2 2026), Cytek Biosciences's total revenue was $48.14M, an increase of 5.57% from the same quarter last year. In Q2, Cytek Biosciences's net income was $-12.16M. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 201.49M | $ 200.45M | $ 193.01M | $ 164.04M | $ 127.95M | |
| $ 104.46M | $ 111.11M | $ 109.43M | $ 100.97M | $ 79.14M | |
| $ 144.84M | $ 131.63M | $ 137.27M | $ 102.78M | $ 69.99M | |
| Depreciation and Amortization | $ 11.97M | $ 10.49M | $ 9.23M | $ 5.66M | $ 1.24M |
| $ -17.39M | $ 4.79M | $ -4.41M | $ 9.49M | $ 8.92M | |
| $ -40.38M | $ -20.52M | $ -27.84M | $ -1.80M | $ 9.16M | |
| $ 10.54M | $ 14.82M | $ 12.14M | $ 3.06M | $ -3.22M | |
| $ -29.84M | $ -5.70M | $ -15.71M | $ 1.26M | $ 5.94M | |
| $ -66.54M | $ -6.02M | $ -12.15M | $ 2.58M | $ 3.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.52 | $ -0.05 | $ -0.09 | $ 0.02 | $ 0.03 |
| Diluted EPS | $ -0.52 | $ -0.05 | $ -0.09 | $ 0.02 | $ 0.03 |
| Weighted Average Shares Outstanding | 127.75M | 130.61M | 135.28M | 134.51M | 133.75M |
| Weighted Average Shares Outstanding (Diluted) | 127.75M | 130.61M | 135.28M | 138.56M | 133.75M |
Currency in USD
